dsp 4 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

dsp 4 has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (25.00)	18.7374
1990's	4 (50.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kondo, T; Narabayashi, H; Nishi, K	2
Goldstein, M; Jonsson, G; Luthman, J; Sundström, E	1
Briley, M; Colpaert, F; Marien, M	1
Barber, A; Boulton, AA; Davis, BA; Durden, DA; Nicklas, WG; Terleckyj, I; Yu, PH	1
Alessandrì, MG; Bassi, L; Corsini, GU; Fornai, F; Torracca, MT	1
Calingasan, NY; Dawson, TM; Dawson, VL; Farah, MH; Flint Beal, M; Leong Lim, K; Mandir, AS; Thomas, B; Trinkaus, DB; von Coelln, R	1
Kostrzewa, RM	1

Reviews

2 review(s) available for dsp 4 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
[A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction]. No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzylamines; Dopamine; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Parkinson Disease, Secondary; Pyridines	1987
Evolution of neurotoxins: from research modalities to clinical realities. Current protocols in neuroscience, 2009, Volume: Chapter 1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic	2009

Article

Year

[A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].

No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:7

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzylamines; Dopamine; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Parkinson Disease, Secondary; Pyridines

1987

Evolution of neurotoxins: from research modalities to clinical realities.

Current protocols in neuroscience, 2009, Volume: Chapter 1

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic

2009

Other Studies

6 other study(ies) available for dsp 4 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa. Neuroscience letters, 1991, Feb-25, Volume: 123, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Benzylamines; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Endings; Neurotoxins; Norepinephrine	1991
Determination of monoamines by use of liquid chromatography with electrochemical detection in the study of selective monoamine neurotoxins. Life sciences, 1987, Aug-17, Volume: 41, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Benzylamines; Brain; Chromatography, High Pressure Liquid; Dopamine; Hydroxydopamines; Neurotoxins; Norepinephrine; Oxidopamine; Pyridines; Rats; Serotonin	1987
Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. European journal of pharmacology, 1993, Jun-04, Volume: 236, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Cerebral Cortex; Corpus Striatum; Dopamine; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Norepinephrine	1993
Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors. Journal of neurochemistry, 1994, Volume: 62, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amines; Amphetamines; Animals; Benzylamines; Brain; Catecholamines; Caudate Nucleus; Hypothalamus; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotoxins; Pargyline; Serotonin	1994
Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Benzylamines; Brain; Corpus Striatum; Dopamine; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Norepinephrine; Substantia Nigra	1997
MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiology of disease, 2007, Volume: 26, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzylamines; Catecholamines; Cell Survival; Cytoprotection; Female; Genetic Predisposition to Disease; Immunity, Innate; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neurotoxins; Norepinephrine; Parkinsonian Disorders; Substantia Nigra; Ubiquitin-Protein Ligases	2007